Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta pseudogene 1 (PIK3CDP1)
- Target
- PIK3CDP1
- Molecular classification
- Other (pseudogene)
01
Overview
PIK3CDP1 is a pseudogene related to phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD). Pseudogenes are non-functional segments of DNA that resemble functional genes but typically do not encode active protein products. Therefore, PIK3CDP1 does not act as a receptor, enzyme, or any therapeutic target. The functional counterpart, PIK3CD (p110δ subunit of PI3K delta), is involved in signal transduction in immune cells and has established roles in immunity and disease, but PIK3CDP1 itself has no direct biological or therapeutic relevance[1][3][5]. Clarification: The entry is not a typical drug target; if your focus is discovery or therapeutic contexts, you likely meant the functional gene/protein PIK3CD, not PIK3CDP1. Information provided here is specific for PIK3CDP1 (the pseudogene), not the functional catalytic subunit delta of PI3K.
- Other names
- PIK3CDP1phosphatidylinositol 3-kinase catalytic delta pseudogene 1
Beyond the preview
Go deeper on phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta pseudogene 1 (PIK3CDP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta pseudogene 1 (PIK3CDP1).